Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Neuropharmacology ; 117: 408-421, 2017 05 01.
Article in English | MEDLINE | ID: mdl-28219718

ABSTRACT

The Regulator of G protein Signalling 4 (RGS4) is a multitask protein that interacts with and negatively modulates opioid receptor signalling. Previously, we showed that the δ-opioid receptor (δ-OR) forms a multiprotein signalling complex consisting of Gi/Go proteins and the Signal Transducer and Activator of Transcription 5B (STAT5B) that leads to neuronal differentiation and neurite outgrowth upon δ-ΟR activation. Here, we investigated whether RGS4 could participate in signalling pathways to regulate neurotropic events. We demonstrate that RGS4 interacts directly with STAT5B independently of δ-ΟR presence both in vitro and in living cells. This interaction involves the N-terminal portion of RGS4 and the DNA-binding SH3 domain of STAT5B. Expression of RGS4 in HEK293 cells expressing δ-OR and/or erythropoietin receptor results in inhibition of [D-Ser2, Leu5, Thr6]-enkephalin (DSLET)-and erythropoietin-dependent STAT5B phosphorylation and subsequent transcriptional activation. DSLET-dependent neurite outgrowth of neuroblastoma cells is also blocked by RGS4 expression, whereas primary cortical cultures of RGS4 knockout mice (RGS4-/-) exhibit enhanced neuronal sprouting after δ-OR activation. Additional studies in adult brain extracts from RGS4-/- mice revealed increased levels of p-STAT5B. Finally, neuronal progenitor cultures from RGS4-/- mice exhibit enhanced proliferation with concomitant increases in the mRNA levels of the anti-apoptotic STAT5B target genes bcl2 and bcl-xl. These observations suggest that RGS4 is implicated in opioid dependent neuronal differentiation and neurite outgrowth via a "non-canonical" signaling pathway regulating STAT5B-directed responses.


Subject(s)
Neurogenesis/physiology , Neuronal Outgrowth/physiology , Neurons/metabolism , RGS Proteins/metabolism , STAT5 Transcription Factor/metabolism , Animals , Cell Line, Tumor , Cell Survival/physiology , Cerebral Cortex/metabolism , HEK293 Cells , Humans , Mice, Inbred C57BL , Mice, Knockout , Neural Stem Cells/metabolism , Phosphorylation/physiology , Proto-Oncogene Proteins c-bcl-2/metabolism , RGS Proteins/genetics , RNA, Messenger/metabolism , Rats , Receptors, Erythropoietin/metabolism , Receptors, Opioid, delta/metabolism , bcl-X Protein/metabolism
2.
Cell Signal ; 27(1): 104-14, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25289860

ABSTRACT

Previous studies have shown that RGS4 associates with the C-termini of µ- and δ-opioid receptors in living cells and plays a key role in Gi/Go protein coupling selectivity and signalling of these receptors [12,20]. To deduce whether similar effects also occur for the κ-opioid receptor (κ-ΟR) and define the ability of members of the Regulators of G protein Signaling (RGS) of the B/R4 subfamily to interact with κ-ΟR subdomains we generated glutathione S-transferase fusion peptides encompassing the carboxyl-termini of κ-OR (κ-CT). Results from pull down experiments indicated that RGS2 and RGS4 directly interact within different domains of the κ-CT. Co-precipitation studies in living cells indicated that RGS2 and RGS4 associate with κ-ΟR constitutively and upon receptor activation and confer selectivity for coupling with a specific subset of G proteins. Expression of both members, RGS2 and/or RGS4, in 293F cells attenuated κ-agonist mediated-adenylyl cyclase inhibition and extracellular signal regulated kinase (ERK1,2) phosphorylation with a different amplitude in their modulatory effect in κ-ΟR signaling. Our findings demonstrate that RGS2 and RGS4 are new interacting partners that play key roles in G protein coupling to negatively regulate κ-ΟR signaling.


Subject(s)
RGS Proteins/metabolism , Receptors, Opioid, kappa/metabolism , Signal Transduction , Adenylyl Cyclase Inhibitors , Adenylyl Cyclases/metabolism , Animals , Endocytosis , Extracellular Signal-Regulated MAP Kinases/metabolism , GTP-Binding Protein alpha Subunits/metabolism , HEK293 Cells , Humans , Mice , Models, Biological , Phosphorylation , Protein Binding , Protein Subunits/metabolism , Receptors, Opioid, delta/metabolism
3.
Cell Signal ; 24(12): 2315-28, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22922354

ABSTRACT

Previous studies have shown that the intracellular domains of opioid receptors serve as platforms for the formation of a multi-component signaling complex consisting of various interacting partners (Leontiadis et al., 2009, Cell Signal. 21, 1218-1228; Georganta et al., 2010, Neuropharmacology, 59(3), 139-148). In the present study we demonstrate that spinophilin a dendritic-spine enriched scaffold protein associates with δ- and µ-opioid receptors (δ-ΟR, µ-OR) constitutively in HEK293 an interaction that is altered upon agonist administration and enhanced upon forskolin treatment for both µ-OR and δ-ΟR. Spinophilin association with the opioid receptors is mediated via the third intracellular loop and a conserved region of the C-terminal tails. The portion of spinophilin responsible for interaction with the δ-OR and µ-OR is narrowed to a region encompassing amino acids 151-444. Spinophilin, RGS4, Gα and Gßγ subunits of G proteins form a multi-protein complex using specific regions of spinophilin and a conserved amino acid stretch of the C-terminal tails of both δ-µ-ORs. Expression of spinophilin in HEK293 cells potentiated DPDPE-mediated adenylyl-cyclase inhibition of δ-OR leaving unaffected the levels of cAMP accumulation mediated by the µ-OR. Moreover, measurements of extracellular signal regulated kinase (ERK1,2) phosphorylation indicated that the presence of spinophilin attenuated agonist-driven ERK1,2 phosphorylation mediated upon activation of the δ-OR but not the µ-OR. Collectively, these findings suggest that spinophilin associates with both δ- and µ-ΟR and G protein subunits in HEK293 cells participating in a multimeric signaling complex that displays a differential regulatory role in opioid receptor signaling.


Subject(s)
GTP-Binding Proteins/metabolism , Microfilament Proteins/metabolism , Nerve Tissue Proteins/metabolism , Receptors, Opioid, delta/metabolism , Receptors, Opioid, mu/metabolism , Adenylyl Cyclases/metabolism , Colforsin/pharmacology , Cyclic AMP/metabolism , Enkephalin, D-Penicillamine (2,5)-/pharmacology , HEK293 Cells , Humans , Microfilament Proteins/genetics , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Nerve Tissue Proteins/genetics , Phosphorylation/drug effects , Protein Binding , Protein Structure, Tertiary , Protein Subunits/metabolism , Receptors, Opioid, delta/agonists , Receptors, Opioid, mu/agonists , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...